Endochin-like quinolones (ELQs) and bumped kinase inhibitors (BKIs): Synergistic and additive effects of combined treatments against Neospora caninum infection in vitro and in vivoINTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCEIF3.42021-12-019OAAI
In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocystsINTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCEIF3.42021-08-0120OAAI
Neospora caninum: Differential Proteome of Multinucleated Complexes Induced by the Bumped Kinase Inhibitor BKI-1294MICROORGANISMSIF4.22020-05-2614OAAI
Neospora caninum: Structure and Fate of Multinucleated Complexes Induced by the Bumped Kinase Inhibitor BKI-1294PATHOGENSIF3.32020-05-1616OAAI
In Vitro Activities of MMV Malaria Box Compounds against the Apicomplexan Parasite Neospora caninum, the Causative Agent of Neosporosis in AnimalsMOLECULESIF4.62020-03-246OAAI
In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninumANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52015-10-0170OAAI
Buparvaquone is active against Neospora caninum in vitro and in experimentally infected miceINTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCEIF3.42015-04-0137OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向